Search research articles
Contact Us
Filters
Showing results (121-130 of 165) with videos related to
Page
of 17
Sort By:
ACS Medicinal Chemistry Letters
|
April 16, 2025
Fragment-Based Discovery of Drug-like LRH-1 Agonists
Alisa Lang, Niklas Ildefeld, Felix F Lillich, et al.
Journal of Medicinal Chemistry
|
June 11, 2021
Propranolol Activates the Orphan Nuclear Receptor TLX to Counteract Proliferation and Migration of Glioblastoma Cells
Giuseppe Faudone, Iris Bischoff-Kont, Lea Rachor, et al.
Journal of Medicinal Chemistry
|
April 1, 2021
Oxaprozin Analogues as Selective RXR Agonists with Superior Properties and Pharmacokinetics
Simone Schierle, Apirat Chaikuad, Felix F Lillich, et al.
Nature Communications
|
June 18, 2024
Chemogenomics for NR1 nuclear hormone receptors
Laura Isigkeit, Espen Schallmayer, Romy Busch, et al.
Journal of Medicinal Chemistry
|
January 18, 2024
Structure-Guided Design of a Highly Potent Partial RXR Agonist with Superior Physicochemical Properties
Max Lewandowski, Melania Carmina, Loris Knümann, et al.
ACS Pharmacology & Translational Science
|
December 20, 2021
The Transcriptional Repressor Orphan Nuclear Receptor TLX Is Responsive to Xanthines
Giuseppe Faudone, Whitney Kilu, Xiaomin Ni, et al.
Chemmedchem
|
November 1, 2019
Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from Zafirlukast
Simone Schierle, Moritz Helmstädter, Jurema Schmidt, et al.
Journal of Medicinal Chemistry
|
September 11, 2024
Tuning RXR Modulators for PGC1α Recruitment
Felix Nawa, Minh Sai, Jan Vietor, et al.
Journal of Medicinal Chemistry
|
May 8, 2025
A First-in-Class Hepatocyte Nuclear Factor 4 Agonist
Espen Schallmayer, Vasily Morozov, Silke Duensing-Kropp, et al.
Angewandte Chemie (International Ed. in English)
|
May 11, 2026
An Agonist/Antagonist Photo-Switchable Vitamin D Mimetic Enables Bidirectional Optical Control of VDR
Xiu Ge, Sabine Willems, Francesco Melfi, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 165) with videos related to
Sort By:
Page
of 17
ACS Medicinal Chemistry Letters
|
April 16, 2025
Fragment-Based Discovery of Drug-like LRH-1 Agonists
Alisa Lang, Niklas Ildefeld, Felix F Lillich, et al.
Journal of Medicinal Chemistry
|
June 11, 2021
Propranolol Activates the Orphan Nuclear Receptor TLX to Counteract Proliferation and Migration of Glioblastoma Cells
Giuseppe Faudone, Iris Bischoff-Kont, Lea Rachor, et al.
Journal of Medicinal Chemistry
|
April 1, 2021
Oxaprozin Analogues as Selective RXR Agonists with Superior Properties and Pharmacokinetics
Simone Schierle, Apirat Chaikuad, Felix F Lillich, et al.
Nature Communications
|
June 18, 2024
Chemogenomics for NR1 nuclear hormone receptors
Laura Isigkeit, Espen Schallmayer, Romy Busch, et al.
Journal of Medicinal Chemistry
|
January 18, 2024
Structure-Guided Design of a Highly Potent Partial RXR Agonist with Superior Physicochemical Properties
Max Lewandowski, Melania Carmina, Loris Knümann, et al.
ACS Pharmacology & Translational Science
|
December 20, 2021
The Transcriptional Repressor Orphan Nuclear Receptor TLX Is Responsive to Xanthines
Giuseppe Faudone, Whitney Kilu, Xiaomin Ni, et al.
Chemmedchem
|
November 1, 2019
Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from Zafirlukast
Simone Schierle, Moritz Helmstädter, Jurema Schmidt, et al.
Journal of Medicinal Chemistry
|
September 11, 2024
Tuning RXR Modulators for PGC1α Recruitment
Felix Nawa, Minh Sai, Jan Vietor, et al.
Journal of Medicinal Chemistry
|
May 8, 2025
A First-in-Class Hepatocyte Nuclear Factor 4 Agonist
Espen Schallmayer, Vasily Morozov, Silke Duensing-Kropp, et al.
Angewandte Chemie (International Ed. in English)
|
May 11, 2026
An Agonist/Antagonist Photo-Switchable Vitamin D Mimetic Enables Bidirectional Optical Control of VDR
Xiu Ge, Sabine Willems, Francesco Melfi, et al.
Page
of 17